Researchers at the Indian Institute of Technology (IIT) Bombay, in collaboration with Monash University, have developed a simpler and gentler approach for **T-cell recovery** from laboratory-grown cultures. This breakthrough aims to enhance the viability and functionality of immune cells essential for T-cell-based cancer immunotherapies, like the crucial CAR T-cell treatment. Professionals interested in the intersection of immunology and advanced treatment modalities should look into specialized training, such as the Certification Course In Clinical Oncology.
Immunotherapy boosts the body’s immune system to recognize and destroy cancer cells. In CAR T-cell therapy, doctors isolate T-cells from a patient’s blood, genetically modify them in a lab to target cancer, and then grow these cells in massive quantities before infusing them back into the patient’s bloodstream. Therefore, finding safe, efficient ways to both grow T-cells and retrieve them is paramount for making these advanced therapies successful.
The Challenge in Lab-Grown T-Cell Recovery
T-cells, although often referred to as “suspension cells” that float freely in liquid, can become tightly lodged when grown in dense, three-dimensional structures. For this study, the IIT Bombay team, led by Prof. Prakriti Tayalia, used specialized electrospun scaffolds. Earlier research indicated that T-cells grown on such scaffolds become more active and multiply rapidly. However, because the cells move deep into the spaces between the fibers, they become quite difficult to remove efficiently. Consequently, if too many healthy cells remain trapped, the process becomes inefficient and expensive.
Prof. Tayalia noted that cell recovery, while sounding simple, is one of the biggest challenges in practice. Without an ample supply of healthy cells, proper testing and delivery of the therapy to patients are severely hampered. Thus, the team tested three distinct methods for collecting T-cells grown in polycaprolactone electrospun scaffolds: simple manual flushing, using the enzyme TrypLE, and using the milder enzyme Accutase.
Accutase Improves T-cell Recovery and Viability
The study demonstrated that manual flushing could not remove all the deeply lodged cells, particularly those stuck at fiber junctions. Furthermore, they observed that TrypLE, a version of the enzyme trypsin commonly used for cell detachment, resulted in higher cell death. Therefore, the researchers found that using Accutase, a milder enzyme designed for gentle cell removal, yielded superior results. Cells recovered with Accutase survived in greater numbers and behaved more like healthy T-cells.
Moreover, the Accutase-recovered cells formed clusters, an essential precursor step for T-cells to divide and grow well after being removed from the scaffold. Significantly, harsh treatments like trypsin can potentially damage key surface proteins. These proteins are vital for immune signaling and activation, thereby reducing the T-cell’s therapeutic effectiveness. Since Accutase is mild enough to avoid this protein damage, it presents a major advantage for clinical-grade cell preparation. Understanding cellular biology and manipulation techniques is key to advancing modern treatment methods.
Future Implications of Efficient T-cell Recovery
This finding could immediately benefit laboratories preparing cells for advanced therapies like CAR T-cell treatment. Because every step matters in bringing advanced therapies to patients, optimizing how cells are grown and retrieved can make a real difference in treatment efficacy. Building on this success, the team has also found that scaffold-grown T-cells are more effective at killing cancer cells. Therefore, researchers plan to test these findings in animal models soon. They also intend to explore the possibility of placing the T-cell-loaded scaffolds directly inside the body. Research into cancer therapeutics strongly benefits from advances in clinical oncology understanding.
Frequently Asked Questions
Q1: What challenge does the new method solve in CAR T-cell therapy?
A: The new method solves the challenge of gently and efficiently recovering T-cells that are grown in dense, three-dimensional electrospun scaffolds. Because T-cells often become tightly lodged in the scaffold fibers, harsh recovery methods can damage their critical surface proteins, reducing their therapeutic effectiveness.
Q2: Why is the enzyme Accutase preferred over TrypLE for T-cell recovery?
A: Accutase is a milder enzyme preparation compared to TrypLE (a trypsin version). Researchers found that using Accutase resulted in T-cells surviving in greater numbers and preserving essential surface proteins necessary for immune signaling. This preservation helps the cells remain active and functional for therapy. A solid background in laboratory techniques is crucial for success in specialized fields.
Q3: What is the significance of T-cells forming clusters after recovery?
A: T-cells forming clusters is an essential biological step that precedes cell division. The fact that Accutase-recovered cells formed clusters indicates that the gentler method kept the cells healthy and functional, allowing them to continue to grow well post-recovery, which is crucial for producing enough therapeutic cells.
References
- IIT Bombay develops simpler method to recover lab-grown immune cells fortreating cancer – ETHealthworld
- IIT Bombay develops method to recover T-cells for cancer therapies – Nagaland Tribune.
- Cell Dissociation Enzymes Affect Annexin V/Flow-Cytometric Apoptotic Assay Outcomes After miRNA-based Transient Transfection – Anticancer Research.
- For cancer immunotherapy, gently recovering lab-grown cells is key. Indian researchers may have just found a way | Explained News – indianexpress.com.
- Can I use accutase solution instead of trypsin to detach the cells? – PromoCell.
- CAR-T cell therapy – Mayo Clinic.
- IIT-B researchers develops simpler method to recover T-cells for cancer therapy – mid-day.com.
- Can I use TrypLE instead of accutase in the rat neural stem cell? – ResearchGate.
- IIT Bombay Develops Gentler Method to Recover T Cells for Cancer Therapies – indianewengland.com.
- Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand – PMC.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.